Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H R Kaplan

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
The Physiologist|October 1, 1984
What a director of pharmacology looks for in a physiologistH R Kaplan
Federation Proceedings|July 1, 1986
Advances in antiarrhythmic drug therapy--changing concepts. IntroductionH R Kaplan
The American Journal of Cardiology|November 26, 1986
Pharmacology of bevantolol hydrochlorideH R Kaplan
Angiology|March 1, 1986
Bevantolol hydrochloride--preclinical pharmacologic profileH R Kaplan
Federation Proceedings|June 1, 1981
Hypertension and antihypertensive drugs: introductory remarksH R Kaplan
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1982
Pirmenol hydrochloride (CI-845) and reference antiarrhythmic agents: effects on early ventricular arrhythmias after acute coronary artery ligation in anesthetized ratsT E Mertz, H R Kaplan
Advance for Nurse Practitioners|June 1, 1997
In transition. Empowering your menopausal patientsH R Kaplan, M L Abisla
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1973
Relative beta adrenergic receptor blocking activity in dogs after intravenous and intraportal vein administration: bunolol, propranolol, their levo isomers and sotalolH R Kaplan, M A Commarato
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1970
The cardiovascular pharmacology of bunolol, a new beta adrenergic blocking agentR D Robson, H R Kaplan
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1970
Antiarrhythmic activity of bunolol, a new beta adrenergic blocking agentH R Kaplan, R D Robson
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
The Physiologist|October 1, 1984
What a director of pharmacology looks for in a physiologistH R Kaplan
Federation Proceedings|July 1, 1986
Advances in antiarrhythmic drug therapy--changing concepts. IntroductionH R Kaplan
The American Journal of Cardiology|November 26, 1986
Pharmacology of bevantolol hydrochlorideH R Kaplan
Angiology|March 1, 1986
Bevantolol hydrochloride--preclinical pharmacologic profileH R Kaplan
Federation Proceedings|June 1, 1981
Hypertension and antihypertensive drugs: introductory remarksH R Kaplan
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1982
Pirmenol hydrochloride (CI-845) and reference antiarrhythmic agents: effects on early ventricular arrhythmias after acute coronary artery ligation in anesthetized ratsT E Mertz, H R Kaplan
Advance for Nurse Practitioners|June 1, 1997
In transition. Empowering your menopausal patientsH R Kaplan, M L Abisla
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1973
Relative beta adrenergic receptor blocking activity in dogs after intravenous and intraportal vein administration: bunolol, propranolol, their levo isomers and sotalolH R Kaplan, M A Commarato
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1970
The cardiovascular pharmacology of bunolol, a new beta adrenergic blocking agentR D Robson, H R Kaplan
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1970
Antiarrhythmic activity of bunolol, a new beta adrenergic blocking agentH R Kaplan, R D Robson
Pageof 5